Institutional investors purchased a net $1.5 million shares of BLRX during the quarter ended December 2017 and now own 38.51% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 1.0 Million shares of BioLine RX Ltd
DZ PRIVATBANK SA Bought 786.2 Thousand shares of BioLine RX Ltd
MORGAN STANLEY & CO. LLC Bought 83.4 Thousand shares of BioLine RX Ltd